Technical Analysis for ABEO - Abeona Therapeutics Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 5.86 | -1.51% | -0.09 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 50 DMA Resistance | Bearish | -1.51% | |
| Stochastic Reached Oversold | Weakness | -1.51% |
| Alert | Time |
|---|---|
| Possible NR7 | 1 day ago |
| 60 Minute Opening Range Breakdown | 1 day ago |
| 2x Volume Pace | 1 day ago |
| Down 2 % | 1 day ago |
| 1.5x Volume Pace | 1 day ago |
Get a Trading Assistant
- Earnings date: 11/11/2024
Abeona Therapeutics Inc. Description
Abeona Therapeutics, Inc., formerly PlasmaTech Biopharmaceuticals, Inc., is focused on developing and delivering gene therapy and plasma-based products for severe and rare diseases. The Company's lead program includes adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB). Its product pipeline includes ABO-101 (sc AAV9 NAGLU), which is used for the treatment of MPS III B; ABO-102 (sc AAV9 SGSH), which is used for the treatment of MPS III A; ABO-201 (sc AAV9 CLN3), which is used for the treatment of Juvenile Batten Disease (JBD); ABO-301 (AAV LK19 FANCC), which is used for the treatment of Fanconi Anemia (FA), and clustered, regularly interspaced short palindromic repeats/CRISPR associated protein 9 (CRISPR/Cas9) gene editing, which is used for treatment of other rare blood diseases. The Company offers two platforms: Salt Diafiltration (SDF) Process and Polymer Hydrogel Technology (PHT).
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Biology Emerging Technologies Rare Diseases Molecular Biology Gene Therapy Genetics Genetic Engineering Anemia CRISPR Genome Editing Adeno Associated Virus Cas9 Severe And Rare Diseases Blood Diseases Fanconi Anemia
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.01 |
| 52 Week Low | 3.05 |
| Average Volume | 261,990 |
| 200-Day Moving Average | 5.73 |
| 50-Day Moving Average | 6.17 |
| 20-Day Moving Average | 6.30 |
| 10-Day Moving Average | 6.18 |
| Average True Range | 0.31 |
| RSI (14) | 38.65 |
| ADX | 15.79 |
| +DI | 16.41 |
| -DI | 17.78 |
| Chandelier Exit (Long, 3 ATRs) | 5.84 |
| Chandelier Exit (Short, 3 ATRs) | 6.73 |
| Upper Bollinger Bands | 6.69 |
| Lower Bollinger Band | 5.90 |
| Percent B (%b) | -0.05 |
| BandWidth | 12.56 |
| MACD Line | -0.06 |
| MACD Signal Line | 0.01 |
| MACD Histogram | -0.0689 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.15 | ||||
| Resistance 3 (R3) | 6.15 | 6.07 | 6.10 | ||
| Resistance 2 (R2) | 6.07 | 5.99 | 6.06 | 6.08 | |
| Resistance 1 (R1) | 5.96 | 5.95 | 5.92 | 5.96 | 6.07 |
| Pivot Point | 5.88 | 5.88 | 5.86 | 5.87 | 5.88 |
| Support 1 (S1) | 5.77 | 5.80 | 5.73 | 5.77 | 5.65 |
| Support 2 (S2) | 5.69 | 5.76 | 5.68 | 5.64 | |
| Support 3 (S3) | 5.58 | 5.69 | 5.62 | ||
| Support 4 (S4) | 5.58 |
